You are here

AusPAR: Insulin degludec (rys) and Insulin aspart (rys)

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

4 August 2020
AusPAR Details
AusPAR
Active Ingredient
Insulin degludec (rys) and Insulin aspart (rys)
Product Name
Ryzodeg 70/30 FlexTouch, Ryzodeg 70/30 Penfill
Sponsor
Novo Nordisk Pharmaceuticals Pty Ltd
Submission Number
PM-2018-04154-1-5
Submission Type
Extension of indications
Decision
Approved
AusPAR Date
17 July 2020
Publication Date

4 August 2020